In contrast, a different study demonstrated that reduction in syndecan-4 expression in melanoma cells resulted in downregulation of FGF-2 signaling, leading to an increase in tumor cell motility and decreased adhesion to fibronectin, demonstrating a regulatory role of syndecan-4 on these cell functions [85]. The gene discussed is SDC4; the disease is melanoma.